3-ETHYL-1,2,3-OXATHIAZOLIDINE 2,2-DIOXIDE, 95.0%, 100mg

N-[(E)-(4-tert-Butylphenyl)methylideneamino]-4-methylbenzenesulfonamide, 95%, 250mg

Éter monoetílico de dietilenglicol, mínimo 99 %, puro, 2,5 l, envase de vidrio

5-Chloro-1,3-benzothiazole-2-carboxylic acid, 97%, 250mg

1-Cyclohexylpiperidine>98.0%(GC)(T)25mL

(R)-(4-BENZYL-6,6-DIMETHYLMORPHOLIN-2-YL)METHANOL, 95.0%, 1g

2-Amino-4-methylphenol, 99.00%, 25g

Chloroacetic anhydride, 100g

2-Fluoro-3-(trifluoromethyl)benzophenone, 97.0%, 25g

Decanediamide, N,N'-bis(3,5-diacetylphenyl)-, 97%, 1g

(S)-2-Amino-3-(pyridazin-3-yl)propanoic acid hydrochloride, 95.0%, 25mg

3-Bromo-4-methyl-1H-pyrrolo[2,3-b]pyridine, 98%, 1g

Citrazinic Acid>96.0%(T)25g